Understanding what to patent versus what to keep as a trade secret is an increasingly important and challenging decision facing companies developing biologics products, such as cell and gene therapies, where technologies are complex and rapidly evolving. Careful consideration of the risks and benefits of each, along with their distinct enforcement considerations, are essential to developing an overall IP strategy to provide robust protection of cell and gene therapy products.
Read the full blog post.
